Phase II single arm trial of Durvalumab rescue in patients with inadequate response to lenalidomide-dexamethasone or high risk oytogenetics for upfront treatment of transplant ineligible patients with multiple myeloma

Project: Research

StatusActive
Effective start/end date1/06/1719/06/20